The combination of vincristine and SPHK2 inhibitor ABC294640 significantly enhanced the inhibition of SPHK2 and further inhibited the survival and proliferation of T-cell acute lymphoblastic leukemia (T-ALL) cells (129). The gene discussed is SPHK2; the disease is T-cell acute lymphoblastic leukemia.